C07C 233/43
Having the carbon atom of the carboxamide group bound to a hydrogen
Official title: having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
C07C233/43 (Having the carbon atom of the carboxamide group bound to a hydrogen) appears on 273 US grants and 232 published applications in this corpus.
Search patents in C07C- Granted patents
- 273
- Published applications
- 232
- Assignees
- 181
- Inventors
- 772
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 9 | 0 |
| 1992 | 6 | 0 |
| 1993 | 10 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 10 | 0 |
| 1999 | 5 | 0 |
| 2000 | 9 | 0 |
| 2001 | 6 | 0 |
| 2002 | 17 | 11 |
| 2003 | 11 | 23 |
| 2004 | 20 | 16 |
| 2005 | 6 | 14 |
| 2006 | 8 | 8 |
| 2007 | 9 | 12 |
| 2008 | 8 | 7 |
| 2009 | 8 | 8 |
| 2010 | 8 | 12 |
| 2011 | 7 | 11 |
| 2012 | 5 | 11 |
| 2013 | 9 | 10 |
| 2014 | 13 | 9 |
| 2015 | 5 | 11 |
| 2016 | 10 | 13 |
| 2017 | 6 | 9 |
| 2018 | 10 | 6 |
| 2019 | 1 | 7 |
| 2020 | 7 | 10 |
| 2021 | 1 | 3 |
| 2022 | 2 | 5 |
| 2023 | 5 | 8 |
| 2024 | 4 | 1 |
| 2025 | 5 | 3 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse26 May 2026US 12,637,410 B2University of Kentucky Research Foundation
- Small-cell polystyrene foams, and process for producing same19 May 2026US 12,630,693 B2Ineos Styrolution Group GmbH
- Budesonide 21-phosphate salts and pharmaceutical compositions containing the same11 Nov 2025US 12,465,614 B2Genetic S.P.A.
- Modulators of TMEM16A for treating respiratory disease16 Sep 2025US 12,415,793 B2TMEM16A Limited
- Substituted piperazines as disrupters of AB42 oligomer formation27 May 2025US 12,312,296 B2Acelot, Inc.
- Ferroptosis inhibitors24 Sep 2026US 2026/0283988 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Budesonide 21-phosphate salts and pharmaceutical compositions containing the same22 Jan 2026US 2026/0021124 A1Genetic S.P.A.
- Anticancer compounds5 Jun 2025US 2025/0179059 A1Poseidon Innovation, LLC
Most cited
By later US patents
- Potent inducers of terminal differentiation and methods of use thereof95US 5,369,108 ASloan-Kettering Institute for Cancer Research · 1994
- Potent inducers of terminal differentiation and methods of use thereof91US 6,087,367 ASloan-Kettering Institute for Cancer Research · 2000
- Potent inducers of terminal differentiation and method of use thereof89US 5,700,811 ASloan-Kettering Institute for Cancer Research · 1997
- Aromatic compounds for inhibiting immune response88US 5,739,169 AProcept, Inc. · 1998
- Backbone polysubstituted chelates for forming a metal chelate-protein conjugate82US 4,831,175 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989